HealthTrust Expands Orthopedic and Spine Care Management Solutions through InVivoLink

Nashville, Tennessee—April 16, 2015 — HealthTrustSM announces today the launch of a new suite of services and partnership with InVivoLink, Inc. to expand their medical device sourcing capabilities. With a broad portfolio of products to monitor patient outcomes, streamline care management and enhance the patient experience, InVivoLink enhances HealthTrust’s mission to strengthen clinical and operational performance in hospitals.

InVivoLink technology offerings enable hospitals, physicians and care teams to capture and assess clinical and financial data before, during and after surgery. The technology enables providers to make better informed decisions to improve outcomes and drive clinical excellence. InVivoLink provides services to HealthTrust members as well as other major health systems.

“InVivoLink provides an efficient and comprehensive solution to capture clinical and financial data specific to our joint replacement service line,” said Steve Schutzer, M.D., medical director of the Connecticut Joint Replacement Institute. “As one of the larger total joint centers in the northeast, we are working with InVivoLink to enhance our outcomes research program and refine our care delivery model for our patients.”

“HealthTrust continuously seeks opportunities to expand its service offerings and InVivoLink presents us with scalable technology to enhance the patient experience and service we provide to our clients,” said Ed Jones, president and CEO of HealthTrust. “I look forward to the ongoing innovation and continued expansion of our suite of services with InVivoLink.”

Jones noted that the knowledge, innovation and experience of the InVivoLink leadership team were key factors in the decision to partner with InVivoLink. Led by Ryan Wells, founder and CEO, the company has seen significant growth over the last two years.

“Elevating clinical excellence remains a primary focus for HealthTrust.  InVivoLink’s technology works to enhance patient care, creating a strategic alignment,” said Wells. “Together with HealthTrust, we have the technology and experience to scale InVivoLink across the U.S. as well as internationally.”

Providers interested in exploring these services can contact HealthTrust at 615.344.3000 or sales@healthtrustpg.com.

About InVivoLink
Based in Nashville, Tennessee, InVivoLink, Inc. is a healthcare technology company that unites surgeons, hospitals, manufacturers and therapists with a platform that helps to optimize patient care. Providing a comprehensive care management solution, InVivoLink maintains an implant registry that tracks outcomes data across the episode of care. InVivoLink equips care teams with tools to collaborate efficiently and real time analytics for operational insight. Dedicated to improving the patient experience, InVivoLink pioneered Your Care Steps as an interactive portal to educate patients throughout their recovery. Founded in 2009, InVivoLink is a leading provider of evidence-based technologies that promotes clinical excellence in orthopedic and spine programs. For more information, visit www.invivolink.com and follow @invivolink.

About HealthTrust
HealthTrust (legally known as HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total cost management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com ) serves 1,350 acute care facilities and members in more than 15,000 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. Headquartered in Brentwood, Tennessee, HealthTrust is an affiliate of Parallon Business Solutions, LLC (www.parallon.com), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions. On Twitter @healthtrustpg and @parallonconnect.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.